Birmingham Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$919K Hold
15,941
0.35% 51
2026
Q1
$967K Sell
15,941
-200
-1% -$11.7K 0.41% 46
2025
Q4
$871K Hold
16,141
0.38% 48
2025
Q3
$728K Sell
16,141
-20,220
-56% -$944K 0.33% 55
2025
Q2
$1.68M Sell
36,361
-6,530
-15% -$321K 0.74% 38
2025
Q1
$2.62M Sell
42,891
-1,000
-2% -$58.3K 0.98% 33
2024
Q4
$2.48M Sell
43,891
-4,050
-8% -$226K 0.92% 36
2024
Q3
$2.48M Buy
47,941
+2,800
+6% +$131K 0.9% 34
2024
Q2
$1.87M Buy
45,141
+1,416
+3% +$63.4K 0.73% 38
2024
Q1
$2.37M Sell
43,725
-315
-0.7% -$16K 0.87% 36
2023
Q4
$2.26M Sell
44,040
-53
-0.1% -$2.78K 0.89% 36
2023
Q3
$2.56M Sell
44,093
-600
-1% -$36.8K 1.06% 31
2023
Q2
$2.86M Buy
44,693
+155
+0.3% +$10.4K 1.2% 29
2023
Q1
$3.09M Buy
44,538
+125
+0.3% +$8.82K 1.23% 29
2022
Q4
$3.2M Hold
44,413
1.21% 26
2022
Q3
$3.16M Hold
44,413
1.4% 25
2022
Q2
$3.42M Hold
44,413
1.36% 27
2022
Q1
$3.24M Sell
44,413
-1,150
-3% -$77.2K 1.13% 30
2021
Q4
$2.84M Buy
45,563
+158
+0.3% +$9.27K 1.03% 34
2021
Q3
$2.69M Sell
45,405
-500
-1% -$32.9K 1.03% 37
2021
Q2
$3.07M Buy
45,905
+30
+0.1% +$1.96K 1.12% 31
2021
Q1
$2.9M Buy
45,875
+425
+0.9% +$26.4K 1.08% 36
2020
Q4
$2.82M Sell
45,450
-440
-1% -$27.1K 1.16% 33
2020
Q3
$2.77M Buy
45,890
+175
+0.4% +$10.5K 1.26% 29
2020
Q2
$2.69M Sell
45,715
-400
-0.9% -$23.9K 1.31% 27
2020
Q1
$2.57M Sell
46,115
-4,500
-9% -$275K 1.42% 24
2019
Q4
$3.25M Sell
50,615
-400
-0.8% -$22.9K 1.44% 24
2019
Q3
$2.59M Sell
51,015
-1,700
-3% -$79.9K 1.19% 27
2019
Q2
$2.39M Sell
52,715
-1,433
-3% -$66.7K 1.08% 30
2019
Q1
$2.58M Sell
54,148
-925
-2% -$46.1K 1.16% 29
2018
Q4
$2.86M Sell
55,073
-5,050
-8% -$271K 1.4% 27
2018
Q3
$3.73M Sell
60,123
-6,450
-10% -$383K 1.54% 25
2018
Q2
$3.68M Sell
66,573
-1,000
-1% -$54K 1.58% 24
2018
Q1
$4.27M Sell
67,573
-3,000
-4% -$193K 1.77% 19
2017
Q4
$4.33M Sell
70,573
-400
-0.6% -$25K 1.66% 23
2017
Q3
$4.52M Hold
70,973
1.8% 21
2017
Q2
$3.96M Hold
70,973
1.59% 27
2017
Q1
$3.86M Buy
70,973
+3,000
+4% +$165K 1.57% 29
2016
Q4
$3.97M Buy
67,973
+1,500
+2% +$82K 1.67% 25
2016
Q3
$4.89M Sell
66,473
-1,400
-2% -$89.9K 2.16% 18
2016
Q2
$4.99M Hold
67,873
2.19% 18
2016
Q1
$4.34M Sell
67,873
-2,260
-3% -$143K 1.76% 24
2015
Q4
$4.82M Sell
70,133
-250
-0.4% -$16.5K 1.96% 18
2015
Q3
$4.17M Sell
70,383
-2,250
-3% -$143K 1.82% 23
2015
Q2
$4.83M Sell
72,633
-2,300
-3% -$152K 1.89% 22
2015
Q1
$4.83M Buy
74,933
+10,931
+17% +$684K 1.84% 21
2014
Q4
$3.78M Sell
64,002
-10,800
-14% -$609K 1.46% 29
2014
Q3
$3.83M Sell
74,802
-600
-0.8% -$30K 1.45% 31
2014
Q2
$3.66M Hold
75,402
1.33% 34
2014
Q1
$3.92M Hold
75,402
1.48% 30
2013
Q4
$4.01M Sell
75,402
-2,000
-3% -$102K 1.51% 29
2013
Q3
$3.58M Sell
77,402
-400
-0.5% -$17.6K 1.42% 28
2013
Q2
$3.48M Buy
+77,802
New +$3.38M 1.44% 29

Other funds holding BMY

Birmingham Capital Management's BMY Position: Q2 2026 in Review

Birmingham Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 15,941 shares worth $919K. The position accounts for 0.35% of the portfolio, ranked #51.

Birmingham Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $4.99M in Q2 2016. 2,505 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Birmingham Capital Management held 15,941 shares of Bristol-Myers Squibb worth $919K as of Q2 2026.
  • Birmingham Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
  • Bristol-Myers Squibb made up 0.35% of Birmingham Capital Management's portfolio in Q2 2026, its #51 holding.
  • Birmingham Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
  • Birmingham Capital Management's Bristol-Myers Squibb position peaked at $4.99M in Q2 2016.
  • 2,505 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Birmingham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.